What is it about?
This paper has to do with changes in quality-of-life and cardiac changes of patients with lower-risk MDS during a one-year follow-up
Featured Image
Why is it important?
It shows that the best tool to follow the loss of funcional capacity in these patients is gait speed monitoring
Read the Original
This page is a summary of: Impact of anaemia on health-related quality of life and cardiac remodelling in patients with lower risk myelodysplastic syndromes. Results of GlobQoL study, European Journal of Cancer Care, January 2016, Wiley,
DOI: 10.1111/ecc.12426.
You can read the full text:
Contributors
The following have contributed to this page
